Garima Verma
Garima Verma publishes mostly in Organic Chemistry, Molecular Biology and Health, Toxicology and Mutagenesis, on topics such as Synthesis and biological activity, Synthesis and Characterization of Heterocyclic Compounds and Synthesis and Biological Evaluation.
- World rank
- #1,728,013 of 7,710,434 ranked researchers
- Rank in India
- #28,394 of 280,097
- Works
- 43
- Citations
- 1.9k
- Citations per work
- 44.8
What does Garima Verma research?
Garima Verma's work is mostly in Chemistry (26%), Biochemistry, Genetics and Molecular Biology (18%), Environmental Science (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1638.0%
- Physical Sciences1535.5%
- Chemistry1125.6%
- Environmental Science25.8%
- Computer Science24.1%
- Life Sciences1023.2%
- Health Sciences13.3%
- Medicine13.3%
- 1Organic Chemistry26% of their works
- 2Molecular Biology18% of their works
- 3Health, Toxicology and Mutagenesis6% of their works
- 4Food Science5% of their works
- 5Computational Theory and Mathematics4% of their works
- 6Endocrinology, Diabetes and Metabolism3% of their works
Research topics
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Biological Evaluation
- Computational Drug Discovery Methods
- Probiotics and Fermented Foods
- Escherichia coli research studies
- Multicomponent Synthesis of Heterocycles
- Effects and risks of endocrine disrupting chemicals
Which keywords describe Garima Verma's research?
The keywords of their largest research topics: Medicinal Chemistry, Anticancer Agents, Heterocyclic Compounds, Tubulin Inhibitors, Vascular Targeting Agents, Molecular Docking, Synthesis and Drug Discovery.
- Pathogenicity
- Green Chemistry
- Endocrine-Disrupting Chemicals
- Probiotics
- Virtual Screening
- Quinoxaline
- Antimicrobial Activity
- Drug Discovery
- Molecular Docking
- Tubulin Inhibitors
- Anticancer Agents
- Medicinal Chemistry
- Heterocyclic Compounds
- Vascular Targeting Agents
- Synthesis
- Antimicrobial
- Drug Target Identification
- Triazines
- Prebiotics
- Bisphenol A
- Escherichia coli
- Multicomponent Reactions
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Medicinal Chemistry243 topics
- Anticancer Agents192 topics
- Heterocyclic Compounds192 topics
- Tubulin Inhibitors141 topic
- Vascular Targeting Agents141 topic
- Molecular Docking102 topics
- Synthesis102 topics
- Drug Discovery82 topics
- Antimicrobial51 topic
- Antimicrobial Activity51 topic
- Drug Target Identification51 topic
- Quinoxaline51 topic
- Triazines51 topic
- Virtual Screening51 topic
- Prebiotics41 topic
- Probiotics41 topic
- Bisphenol A31 topic
- Endocrine-Disrupting Chemicals31 topic
- Escherichia coli31 topic
- Green Chemistry31 topic
- Multicomponent Reactions31 topic
- Pathogenicity31 topic
Where does Garima Verma work?
Garima Verma's main affiliation in the publication record is Jamia Hamdard, India.
How many publications and citations does Garima Verma have?
OpenAlex counts 43 works and 1,926 citations for Garima Verma, an h-index of 18, ranking #1,728,013 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Garima Verma
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Garima Verma. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.